El apixaban se asocia a un menor riesgo de sangrado que los antagonistas de la vitamina K / Apixaban is associated with a lower risk of bleeding than vitamin K antagonists
Evid. actual. práct. ambul
;
21(2): 54-54, jul. 2018. tab.
Article
in Spanish
| LILACS
| ID: biblio-1016287
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Pyrazoles
/
Pyridones
/
Vitamin K
/
Venous Thromboembolism
/
Hemorrhage
/
Anticoagulants
Type of study:
Controlled clinical trial
/
Etiology study
/
Incidence study
/
Prognostic study
/
Risk factors
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Evid. actual. práct. ambul
Journal subject:
Medicine
/
Delivery of Health Care
Year:
2018
Type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital Italiano de Buenos Aires/AR
Similar
MEDLINE
...
LILACS
LIS